Top Stories

IDEXX Raises 2026 EPS Outlook Following Double-Digit Second-Quarter Revenue Growth

IDEXX Laboratories reported second-quarter 2026 revenue of $1.22 billion, driven by continued growth in companion animal diagnostics, and increased its full-year earnings outlook while modestly raising its revenue guidance. A summary of the company’s financial performance is below. The complete earnings report is available at https://www.idexx.com/investors/.

Cochliomyia hominivorax, the New World screw-worm fly, or screw-worm for short

Veterinarians Face New Wound Care Challenges as New World Screwworm Returns to the U.S.

The return of New World screwworm (NWS) to the United States for the first time in more than six decades is reshaping how veterinarians approach wound management in companion animals and horses. Because the parasite lays eggs in open wounds where larvae feed on living tissue, experts say even routine injuries—from surgical incisions and hot spots to paw pad punctures and minor lacerations—require prompt attention. Vetoquinol USA is encouraging veterinary teams to strengthen client education, increase wound surveillance, and consider therapies that promote faster healing to help reduce the risk of infestation as the parasite expands its U.S. presence.

Never Miss an Animal Health Story

Sign up for free to receive the latest veterinary news, product announcements, and industry developments.